SCHEMBL4516147

SCHEMBL4516147

O=C(O)Nc1cnn(Cc2ccc(F)cc2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.70
SMN1; SMN2 Q16637 5/20 0.64
TCF4 P15884 1/20 0.63
CTNNB1 P35222 1/20 0.63
ALDH1A1 P00352 5/20 0.62
MAPT P10636 4/20 0.62
HTT P42858 3/20 0.62
MAPK1 P28482 1/20 0.62
RAB9A P51151 2/20 0.58
NPC1 O15118 1/20 0.57
KDM4E B2RXH2 2/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
HSD17B10 Q99714 2/20 0.56
SCD5 Q86SK9 2/20 0.56
POLB P06746 1/20 0.56
HDAC3 O15379 1/20 0.53
HDAC8 Q9BY41 1/20 0.53
NCOR2 Q9Y618 1/20 0.53
GBA1 P04062 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28522992 0.79 LMNA (0.58) LMNASMN1; SMN2TCF4CTNNB1ALDH1A1
SCHEMBL22557130 0.78 SMN1; SMN2 (0.62) LMNASMN1; SMN2TCF4CTNNB1ALDH1A1
Hydrochloric Acid SCHEMBL28517900 0.78 LMNA (0.60) LMNASMN1; SMN2TCF4CTNNB1ALDH1A1
SCHEMBL949903 0.78 HSD17B10 (0.61) LMNASMN1; SMN2TCF4CTNNB1ALDH1A1
SCHEMBL4490664 0.77 ALDH1A1 (0.64) LMNASMN1; SMN2ALDH1A1MAPTHTT
SCHEMBL19252863 0.77 LMNA (0.56) LMNASMN1; SMN2ALDH1A1MAPTHTT
SCHEMBL18593075 0.75 HDAC3 (0.64) LMNASMN1; SMN2ALDH1A1MAPTHTT
SCHEMBL4506087 0.74 ALDH1A1 (0.68) LMNASMN1; SMN2TCF4CTNNB1ALDH1A1
SCHEMBL3469650 0.74 LMNA (0.53) LMNASMN1; SMN2TCF4CTNNB1ALDH1A1
SCHEMBL4283175 0.74 NAMPT (0.69) SMN1; SMN2ALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325956-A1 Aromatic amine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325956-A1 Aromatic amine derivative and use thereof SCD, SCD5, SMS LMNA 247/4885SMN1; SMN2 2075/4885TCF4 3626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.